8-KItem 5.02 · Officer/Director ChangeItem 9.01 · Financial Statements
HCA filed an 8‑K on Feb 25, 2026 disclosing Exhibit 10.1 — "HCA Healthcare, Inc.
Filed with the SEC on · Summarized by InvestorsBot
HCA filed an 8‑K on Feb 25, 2026 disclosing Exhibit 10.1 — "HCA Healthcare, Inc. 2026 Executive Officer Performance Excellence Program." New executive incentive program added. $HCA 📝📈 #ExecComp #CorporateGovernance
Exhibit 10.1 contains the program terms — investors should review for changes to executive pay, performance metrics and potential compensation expense. 8‑K also includes Exhibit 104 (iXBRL cover page). $HCA 🔎 #HCA #InvestorAlert
Form 8‑K signed Feb 25, 2026 by John M. Franck II, VP–Legal & Corporate Secretary. See filed Exhibit 10.1 for full details on the 2026 executive program. $HCA 🖋️ #HCA #CorporateUpdate